| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF141 ZNF486 ZSCAN12 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF57 ZNF226 ZNF229 ZNF519 ZNF529 ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 PITX3 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 5.63e-23 | 1412 | 103 | 43 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF141 ZNF486 ZSCAN12 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF57 ZNF226 ZNF229 ZNF519 ZNF529 ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 PITX3 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 2.03e-22 | 1459 | 103 | 43 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF141 ZNF486 ZSCAN12 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF226 ZNF229 ZNF519 ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 PITX3 ZNF286B ZNF814 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 4.30e-21 | 1244 | 103 | 39 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF141 ZNF486 ZSCAN12 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF226 ZNF229 ZNF519 ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 PITX3 ZNF286B ZNF814 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 9.19e-21 | 1271 | 103 | 39 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF48 ZBTB17 ZNF473 ZNF175 ZNF485 MECOM ZNF226 ZNF229 ZNF519 CTCFL BRCA1 ZNF544 MZF1 PITX3 ZNF814 ZNF99 ZNF726 ZNF445 | 6.27e-10 | 566 | 103 | 18 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF48 ZBTB17 ZNF473 ZNF175 ZNF485 MECOM ZNF226 ZNF229 ZNF519 CTCFL ZNF544 MZF1 PITX3 ZNF814 ZNF99 ZNF726 ZNF445 | 3.98e-09 | 560 | 103 | 17 | GO:0001228 |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle cell differentiation | 2.57e-05 | 12 | 103 | 3 | GO:2000726 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF48 ZBTB17 ZNF473 ZNF175 ZNF485 MECOM ZNF226 ZNF229 DLL1 HDAC3 CTCFL BRCA1 ZNF544 MZF1 PITX3 ZNF814 CAMTA1 ZNF99 ZNF445 | 5.22e-05 | 1390 | 103 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of cardiocyte differentiation | 5.27e-05 | 15 | 103 | 3 | GO:1905208 | |
| Domain | - | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 1.97e-37 | 679 | 103 | 45 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 4.86e-37 | 693 | 103 | 45 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 5.19e-37 | 694 | 103 | 45 | IPR013087 |
| Domain | Znf_C2H2 | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ADAMTS17 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 1.91e-35 | 805 | 103 | 46 | IPR007087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 6.74e-35 | 775 | 103 | 45 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 7.54e-35 | 777 | 103 | 45 | PS00028 |
| Domain | Znf_C2H2-like | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 2.17e-34 | 796 | 103 | 45 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF141 ZNF486 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 4.18e-34 | 808 | 103 | 45 | SM00355 |
| Domain | KRAB | ZNF141 ZNF486 ZNF473 ZNF569 ZNF175 ZNF549 ZNF316 ZNF485 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZNF529 ZNF334 ZNF544 ZNF257 ZNF641 ZNF814 ZNF81 ZNF221 ZNF565 ZNF418 ZNF99 ZNF738 ZNF726 ZNF445 | 1.01e-24 | 358 | 103 | 28 | PS50805 |
| Domain | KRAB | ZNF141 ZNF486 ZNF473 ZNF569 ZNF175 ZNF549 ZNF316 ZNF485 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZNF529 ZNF334 ZNF544 ZNF257 ZNF641 ZNF814 ZNF81 ZNF221 ZNF565 ZNF418 ZNF99 ZNF738 ZNF726 ZNF445 | 1.01e-24 | 358 | 103 | 28 | PF01352 |
| Domain | KRAB | ZNF141 ZNF486 ZNF473 ZNF569 ZNF175 ZNF549 ZNF316 ZNF485 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZNF529 ZNF334 ZNF544 ZNF257 ZNF641 ZNF814 ZNF81 ZNF221 ZNF565 ZNF418 ZNF99 ZNF738 ZNF726 ZNF445 | 2.34e-24 | 369 | 103 | 28 | SM00349 |
| Domain | KRAB | ZNF141 ZNF486 ZNF473 ZNF569 ZNF175 ZNF549 ZNF316 ZNF485 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZNF529 ZNF334 ZNF544 ZNF257 ZNF641 ZNF814 ZNF81 ZNF221 ZNF565 ZNF418 ZNF99 ZNF738 ZNF726 ZNF445 | 2.52e-24 | 370 | 103 | 28 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF141 ZNF486 ZNF48 ZNF473 ZNF569 ZNF549 ZNF316 MECOM ZNF229 ZNF260 ZNF16 ZNF334 ZNF814 ZNF80 ZNF418 ZNF99 ZNF726 ZNF445 | 1.07e-13 | 314 | 103 | 18 | PF13912 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF141 ZNF486 ZNF473 ZNF569 ZNF175 ZNF549 CASP1 ZNF485 ZNF233 ZNF226 ZNF519 ZNF230 PTEN DLL1 ZNF529 HDAC3 BRCA1 ZNF334 ZNF544 ZNF257 ZNF641 ZNF221 ZNF565 ZNF418 ZNF99 ZNF738 ZNF726 ZNF697 ZNF445 | 2.27e-12 | 1387 | 69 | 29 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF473 ZNF569 ZNF226 ZNF519 HDAC3 BRCA1 ZNF641 ZNF286B ZNF814 ZNF221 ZNF418 ZNF99 ZNF726 ZNF445 | 1.70e-05 | 768 | 69 | 14 | MM14851 |
| Pubmed | ZNF486 ZNF569 ZNF316 ZNF485 ZNF57 ZNF229 ZNF529 ZNF257 ZNF738 ZNF726 ZNF697 ZNF445 | 3.11e-13 | 181 | 104 | 12 | 37372979 | |
| Pubmed | ZSCAN12 ZNF48 ZBTB17 ZNF473 ZNF569 HSPBAP1 ZNF175 ZBTB43 ZNF322 DLL1 ZNF260 ZNF334 ZFP36L2 ZNF286B ZNF99 ZNF726 ZNF697 ZNF445 | 3.31e-11 | 808 | 104 | 18 | 20412781 | |
| Pubmed | 3.25e-09 | 20 | 104 | 5 | 12743021 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 7.78e-09 | 49 | 104 | 6 | 9630514 | |
| Pubmed | Characterization and mapping of human genes encoding zinc finger proteins. | 5.29e-07 | 22 | 104 | 4 | 1946370 | |
| Pubmed | 5.29e-07 | 22 | 104 | 4 | 1505991 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25239453 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 16166646 | ||
| Pubmed | PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas. | 8.86e-06 | 2 | 104 | 2 | 35263698 | |
| Pubmed | Dose-dependent activation of putative oncogene SBSN by BORIS. | 8.86e-06 | 2 | 104 | 2 | 22792300 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10449921 | ||
| Pubmed | p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer. | 8.86e-06 | 2 | 104 | 2 | 37345432 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 8268913 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23636253 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22777348 | ||
| Pubmed | 2.43e-05 | 284 | 104 | 7 | 15057824 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28513615 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 22628410 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 32754899 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17636424 | ||
| Pubmed | Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. | 2.65e-05 | 3 | 104 | 2 | 25652109 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 34793697 | ||
| Pubmed | BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation. | 2.65e-05 | 3 | 104 | 2 | 30254159 | |
| Pubmed | p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. | 2.65e-05 | 3 | 104 | 2 | 16738322 | |
| Pubmed | Molecular Analysis of AFP and HSA Interactions with PTEN Protein. | 2.65e-05 | 3 | 104 | 2 | 26078940 | |
| Pubmed | 2.85e-05 | 20 | 104 | 3 | 7479878 | ||
| Pubmed | 2.85e-05 | 20 | 104 | 3 | 2542606 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 26986465 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9244436 | ||
| Pubmed | LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis. | 5.29e-05 | 4 | 104 | 2 | 31212131 | |
| Pubmed | PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. | 5.29e-05 | 4 | 104 | 2 | 30540933 | |
| Pubmed | Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression. | 5.29e-05 | 4 | 104 | 2 | 29996906 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 28498467 | ||
| Pubmed | Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. | 5.29e-05 | 4 | 104 | 2 | 21289308 | |
| Pubmed | Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells. | 5.29e-05 | 4 | 104 | 2 | 30590041 | |
| Pubmed | 8.06e-05 | 28 | 104 | 3 | 16109169 | ||
| Pubmed | Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis. | 8.80e-05 | 5 | 104 | 2 | 28652244 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 24332043 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 34090924 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZNF146 ZBTB17 ZNF175 ZNF322 ZNF230 ZNF16 CTCFL ZFP36L2 MZF1 PITX3 CAMTA1 | 8.87e-05 | 908 | 104 | 11 | 19274049 |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 24220145 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 17873065 | ||
| Pubmed | High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease. | 1.32e-04 | 6 | 104 | 2 | 28608929 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 18625706 | ||
| Pubmed | FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response. | 1.32e-04 | 6 | 104 | 2 | 22792074 | |
| Pubmed | Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression. | 1.32e-04 | 6 | 104 | 2 | 31811908 | |
| Pubmed | The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity. | 1.32e-04 | 6 | 104 | 2 | 26766587 | |
| Pubmed | Misguided transcriptional elongation causes mixed lineage leukemia. | 1.32e-04 | 6 | 104 | 2 | 19956800 | |
| Pubmed | 1.45e-04 | 34 | 104 | 3 | 32152128 | ||
| Pubmed | 1.73e-04 | 172 | 104 | 5 | 20628624 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 29523594 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 11867212 | ||
| Pubmed | Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency. | 1.84e-04 | 7 | 104 | 2 | 34750509 | |
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 26424886 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF473 ZNF175 ZBTB43 ZNF226 ZNF519 HDAC3 BRCA1 MZF1 ZNF641 PITX3 | 3.05e-04 | 877 | 104 | 10 | 20211142 |
| Pubmed | Negative Feedback Loop Mechanism between EAF1/2 and DBC1 in Regulating ELL Stability and Functions. | 3.14e-04 | 9 | 104 | 2 | 36036574 | |
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 23436574 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 22567161 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 30905671 | ||
| Pubmed | Gene structure and evolution of testicular haploid germ cell-specific genes, Oxct2a and Oxct2b. | 3.14e-04 | 9 | 104 | 2 | 15028287 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.75e-04 | 120 | 104 | 4 | 31413325 | |
| Pubmed | 4.79e-04 | 11 | 104 | 2 | 20694014 | ||
| Pubmed | Dkk1 regulates ventral midbrain dopaminergic differentiation and morphogenesis. | 4.79e-04 | 11 | 104 | 2 | 21347250 | |
| Pubmed | ZNF146 ZNF48 NT5E RPP40 WDR55 HDAC3 BRCA1 ZFP36L2 SMU1 MACF1 PPIE EIF3B NOL8 | 5.30e-04 | 1497 | 104 | 13 | 31527615 | |
| Pubmed | Genetically engineered mouse models of brain cancer and the promise of preclinical testing. | 5.73e-04 | 12 | 104 | 2 | 19076778 | |
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 9917000 | ||
| Pubmed | A mouse chromosome 19 genetic map including the Lvis1 viral insertion site. | 5.73e-04 | 12 | 104 | 2 | 10051411 | |
| Pubmed | 5.73e-04 | 12 | 104 | 2 | 1797234 | ||
| Pubmed | 6.76e-04 | 13 | 104 | 2 | 26989192 | ||
| Pubmed | 7.87e-04 | 14 | 104 | 2 | 20338046 | ||
| Pubmed | Chromosomal location of fifteen unique mouse KRAB-containing zinc finger loci. | 8.24e-04 | 61 | 104 | 3 | 8662221 | |
| Pubmed | 9.07e-04 | 15 | 104 | 2 | 15885501 | ||
| Pubmed | 9.48e-04 | 64 | 104 | 3 | 24431302 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 9.90e-04 | 146 | 104 | 4 | 20686565 | |
| Pubmed | 1.03e-03 | 16 | 104 | 2 | 18257070 | ||
| Pubmed | Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. | 1.03e-03 | 16 | 104 | 2 | 16410412 | |
| Pubmed | Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. | 1.17e-03 | 17 | 104 | 2 | 21076409 | |
| Pubmed | PTEN Regulates Glucose Transporter Recycling by Impairing SNX27 Retromer Assembly. | 1.17e-03 | 17 | 104 | 2 | 29117568 | |
| Pubmed | 1.18e-03 | 69 | 104 | 3 | 16541075 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.31e-03 | 18 | 104 | 2 | 35503090 | |
| Pubmed | A beta-catenin gradient links the clock and wavefront systems in mouse embryo segmentation. | 1.31e-03 | 18 | 104 | 2 | 18157121 | |
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 1.46e-03 | 19 | 104 | 2 | 14578343 | |
| Pubmed | ZNF473 ZNF569 ZFYVE1 TMEFF1 TYW1B AFF1 MACF1 CAMTA1 ZNF726 ZNF445 | 1.54e-03 | 1084 | 104 | 10 | 11544199 | |
| Pubmed | 1.62e-03 | 20 | 104 | 2 | 15979417 | ||
| Pubmed | 1.79e-03 | 21 | 104 | 2 | 17670789 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 1.91e-03 | 431 | 104 | 6 | 33660365 | |
| Pubmed | Pten coordinates retinal neurogenesis by regulating Notch signalling. | 1.97e-03 | 22 | 104 | 2 | 22258620 | |
| Pubmed | Modulation of apical constriction by Wnt signaling is required for lung epithelial shape transition. | 1.97e-03 | 22 | 104 | 2 | 27913639 | |
| Pubmed | 1.97e-03 | 22 | 104 | 2 | 30089695 | ||
| Pubmed | Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens. | 1.97e-03 | 22 | 104 | 2 | 7590745 | |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 2.01e-03 | 177 | 104 | 4 | 22560297 | |
| Pubmed | 2.34e-03 | 24 | 104 | 2 | 21037509 | ||
| Pubmed | Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. | 2.54e-03 | 25 | 104 | 2 | 17397913 | |
| Pubmed | Murine craniofacial development requires Hdac3-mediated repression of Msx gene expression. | 2.75e-03 | 26 | 104 | 2 | 23506836 | |
| Pubmed | 2.75e-03 | 26 | 104 | 2 | 26912775 | ||
| Pubmed | Specific and integrated roles of Lmx1a, Lmx1b and Phox2a in ventral midbrain development. | 2.75e-03 | 26 | 104 | 2 | 21752929 | |
| Pubmed | 2.86e-03 | 94 | 104 | 3 | 16325481 | ||
| Pubmed | 2.96e-03 | 27 | 104 | 2 | 31308417 | ||
| Pubmed | 2.96e-03 | 27 | 104 | 2 | 24586749 | ||
| Interaction | ZNF667 interactions | 2.74e-07 | 53 | 102 | 6 | int:ZNF667 | |
| Interaction | ZNF710 interactions | 3.88e-07 | 30 | 102 | 5 | int:ZNF710 | |
| Interaction | ZNF287 interactions | 5.81e-07 | 60 | 102 | 6 | int:ZNF287 | |
| Interaction | TRIM28 interactions | ZNF486 PMPCB ZNF569 ZNF316 CASP1 ZNF485 ZNF57 ZNF226 ZNF229 PTEN ZNF529 HDAC3 BRCA1 ZNF544 ZNF257 SMU1 ZNF81 ZNF418 USP27X ZNF738 ZNF726 ZNF697 ZNF445 | 9.54e-07 | 1474 | 102 | 23 | int:TRIM28 |
| Interaction | ZFP37 interactions | 4.81e-06 | 49 | 102 | 5 | int:ZFP37 | |
| Interaction | PRDM4 interactions | 6.47e-06 | 52 | 102 | 5 | int:PRDM4 | |
| Interaction | ZNF473 interactions | 9.36e-06 | 56 | 102 | 5 | int:ZNF473 | |
| Interaction | ZFP62 interactions | 1.11e-05 | 99 | 102 | 6 | int:ZFP62 | |
| Interaction | CTCFL interactions | 1.55e-05 | 62 | 102 | 5 | int:CTCFL | |
| Interaction | ZNF513 interactions | 2.55e-05 | 34 | 102 | 4 | int:ZNF513 | |
| Interaction | ZNF652 interactions | 2.87e-05 | 35 | 102 | 4 | int:ZNF652 | |
| Interaction | ZNF423 interactions | 3.44e-05 | 73 | 102 | 5 | int:ZNF423 | |
| Interaction | ZFP28 interactions | 3.59e-05 | 37 | 102 | 4 | int:ZFP28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF146 ZNF473 ZNF569 ZNF175 ZNF549 ZNF233 ZNF226 ZNF229 ZNF230 ZNF529 SBSN ZNF260 ZNF544 MZF1 ZNF814 ZNF221 ZNF83 ZNF565 ZNF418 | 2.42e-11 | 1192 | 104 | 19 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 9.09e-06 | 122 | 104 | 5 | chr19p12 | |
| Cytoband | 19q13.31 | 3.95e-05 | 29 | 104 | 3 | 19q13.31 | |
| Cytoband | 19q13.43 | 4.79e-05 | 87 | 104 | 4 | 19q13.43 | |
| Cytoband | 19p12 | 5.47e-05 | 90 | 104 | 4 | 19p12 | |
| Cytoband | 19q13.13 | 5.23e-04 | 15 | 104 | 2 | 19q13.13 | |
| Cytoband | 19q13.12 | 6.01e-04 | 72 | 104 | 3 | 19q13.12 | |
| Cytoband | 1p32 | 1.72e-03 | 27 | 104 | 2 | 1p32 | |
| Cytoband | 3q26.2 | 1.72e-03 | 27 | 104 | 2 | 3q26.2 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF141 ZNF486 ZSCAN12 ZNF146 ZNF48 ZBTB17 ZNF473 ZFP3 ZNF165 ZNF569 ZNF175 ZNF549 ZBTB43 ZNF316 ZNF485 MECOM ZNF322 ZNF233 ZNF57 ZNF226 ZNF229 ZNF519 ZNF230 ZXDA ZNF529 ZXDB ZNF260 ZNF16 CTCFL ZNF334 ZNF544 MZF1 ZNF257 ZNF641 ZNF286B ZNF814 ZNF80 ZNF81 ZNF221 ZNF83 ZNF565 ZNF418 ZNF99 ZNF726 ZNF697 ZNF445 | 5.25e-43 | 718 | 82 | 46 | 28 |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.56e-06 | 152 | 104 | 6 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.88e-06 | 169 | 104 | 6 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-06 | 188 | 104 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-06 | 192 | 104 | 6 | 522d1bb15edf1d6006b80289bd3baadb99584ae8 | |
| ToppCell | proximal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-06 | 192 | 104 | 6 | f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9 | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.99e-06 | 192 | 104 | 6 | 57899a905ca3e336bb7f31edc6418a2546b9891a | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-06 | 192 | 104 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| Disease | fatty acid measurement | 1.52e-05 | 436 | 98 | 9 | EFO_0005110 | |
| Disease | hepatitis (biomarker_via_orthology) | 6.52e-05 | 4 | 98 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | Atypical Endometrial Hyperplasia | 1.08e-04 | 5 | 98 | 2 | C0349579 | |
| Disease | Complex Endometrial Hyperplasia | 1.08e-04 | 5 | 98 | 2 | C0349578 | |
| Disease | Simple Endometrial Hyperplasia | 1.08e-04 | 5 | 98 | 2 | C0456483 | |
| Disease | Endometrial Hyperplasia | 1.08e-04 | 5 | 98 | 2 | C0014173 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.97e-04 | 34 | 98 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | CDKN2C ADAMTS19 ZNF569 MECOM PTEN DLL1 BMP1 DKK1 BRCA1 AFP AFF1 MACF1 | 2.32e-04 | 1074 | 98 | 12 | C0006142 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 3.87e-04 | 9 | 98 | 2 | C4225275 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.55e-04 | 200 | 98 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 7.38e-04 | 53 | 98 | 3 | EFO_0022286 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.39e-04 | 447 | 98 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | cholesterol to total lipids in large HDL percentage | 8.22e-04 | 55 | 98 | 3 | EFO_0022234 | |
| Disease | triacylglycerol 46:2 measurement | 9.68e-04 | 14 | 98 | 2 | EFO_0010402 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 9.68e-04 | 14 | 98 | 2 | C0677776 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.01e-03 | 59 | 98 | 3 | EFO_0022248 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.33e-03 | 243 | 98 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.60e-03 | 150 | 98 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.94e-03 | 74 | 98 | 3 | EFO_0022280 | |
| Disease | Adenocarcinoma of prostate | 2.00e-03 | 20 | 98 | 2 | C0007112 | |
| Disease | in situ carcinoma (is_marker_for) | 2.20e-03 | 21 | 98 | 2 | DOID:8719 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.31e-03 | 276 | 98 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 2.64e-03 | 23 | 98 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | Leukemia, Myelocytic, Acute | 2.69e-03 | 173 | 98 | 4 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGSVHHKCNSAKHRI | 271 | Q9Y6Y1 | |
| TGHKKRGFHCESSAH | 411 | P55884 | |
| KLTGSKFDCALHGNH | 181 | Q96FG2 | |
| LHRHSEKCGSGEAKS | 561 | Q8NI51 | |
| KGSFGTAVRHCDEHR | 2001 | Q9HCU4 | |
| SGFVLHDNKHDCKEA | 731 | P13497 | |
| GKTCHLVKGDFSHAR | 696 | Q8TE56 | |
| RKDGAHFFVTSCGHI | 11 | A8MTL3 | |
| GKKEMHAFQCSHRGG | 246 | P30039 | |
| HKITGRHGNECFSSE | 1116 | Q8TE59 | |
| NKHRRFCEGKNHFAA | 421 | Q03112 | |
| GKKSSFPTCAHHGQE | 216 | Q9P2P5 | |
| KLHKFTDCGHFQNTE | 156 | O75884 | |
| AKFHFGDSLCTHKGE | 256 | O75439 | |
| EVGKGCDFHISSHSK | 86 | Q8NA72 | |
| FDQDKKRSIHFDHGG | 536 | Q6UY01 | |
| NHCGEKFHSEVAKFR | 91 | Q9UJY4 | |
| AKTHNIGFDKDSCHS | 686 | Q76FK4 | |
| NFGCKLGSHGKRNSH | 366 | O00222 | |
| GGLHHAKKFEASGFC | 131 | O15379 | |
| HHQGSKSDDKLCGTL | 3216 | Q9UPN3 | |
| HGCSKDNRNDTEGFK | 816 | P38398 | |
| DGEHFGKLHCAKRQQ | 421 | Q96EW2 | |
| GHRNHKGDTACDLAR | 131 | P42773 | |
| LHGKDFQVDCKASGS | 2051 | Q6WRI0 | |
| SHGIREGICGKKHSE | 236 | P29466 | |
| FHGDHSADKNGFKAR | 621 | O00548 | |
| CYHLDANSKHGTKAN | 456 | Q9H972 | |
| RHTQVCKASALKHGG | 336 | Q5D0E6 | |
| EGQVCTKHRRKGSHG | 216 | O94907 | |
| CTHEKGFGFKGSSFH | 176 | Q9UNP9 | |
| HAKEKNGGCYSELHV | 286 | A6NIM6 | |
| HAASQFGKETEKLGH | 356 | Q6UWP8 | |
| KEAEKFGQGVHHAAS | 381 | Q6UWP8 | |
| HGCKGQEHSDSEKAS | 31 | O75364 | |
| QSEEGRHNCFLAHKK | 116 | P02771 | |
| KCKHKTHIFGADGAR | 246 | Q8TB37 | |
| DNHVAAIHCKAGKGR | 116 | P60484 | |
| HENCVHKASRVSKGG | 446 | Q9Y6K5 | |
| SECGKAFSQKSHHIR | 271 | Q15072 | |
| AECHDHGSTFQGRKK | 16 | Q9GZY0 | |
| VCEKSNFGNHKSRHR | 16 | O75818 | |
| HGCKAQAHTKEVGRT | 1926 | O95425 | |
| SLGAGEFKSQEHAKH | 851 | P12259 | |
| QVSLKSDEHHFCGGS | 61 | Q7RTY7 | |
| KARHSTCKDSGHAGA | 76 | Q14181 | |
| HHEGKQFICSHSDGT | 246 | Q5T5C0 | |
| DFGLAKCNGLSHSHD | 161 | P57078 | |
| AVEGRIKFSTGSHCH | 541 | P21589 | |
| QEGFGSSHHKKGDRR | 166 | P51825 | |
| KHFHEANEDCISKGG | 86 | O75596 | |
| QCGKSFTHKSQRDRH | 376 | O43298 | |
| ECGKAFNHFSALRKH | 681 | A8MXY4 | |
| CGKSFTRAEHLKGHS | 491 | P98169 | |
| KHEECGKGFNHSTTL | 261 | Q8NE65 | |
| LHRHCKGDDVGKAAN | 176 | A6NNY8 | |
| CGKGFRRSSDLVKHH | 456 | Q96MX3 | |
| ECGKAFSRGSHLIQH | 211 | Q8N9K5 | |
| VCGKSFRHKQTFVGH | 336 | Q6P9A3 | |
| CKSGFDPRHGSHNIK | 61 | Q9H2L4 | |
| SECGKAFSQKSHHIR | 391 | Q3ZCT1 | |
| ECGKAFNRGSHLTRH | 436 | Q8TB69 | |
| RTHTGEKHGVFNKCG | 481 | Q9HCZ1 | |
| SRHIKFGQKSHVECA | 206 | Q2TAY7 | |
| GHQRTHAGKKFYTCD | 116 | Q6U7Q0 | |
| RHTGEKHFKECGKSF | 166 | Q15928 | |
| ECGKGFRRNSDLHSH | 576 | Q9UJW7 | |
| CGKGFRCTSSLHKHQ | 661 | Q9UJW7 | |
| FKDNDTKHHCRACGE | 611 | Q9HBF4 | |
| ECGKGFGRNSHLVNH | 441 | Q5TEC3 | |
| ECGKEFSQGAHLQTH | 311 | Q9NYT6 | |
| ECGKAFHRSSNLTKH | 401 | A6NNF4 | |
| HRVTHTGEKLFGCKE | 151 | P51504 | |
| HKCEDCGKEFTHTGN | 306 | Q13105 | |
| CGKEFTHTGNFKRHI | 311 | Q13105 | |
| VCGKDFSLSSHHQRG | 461 | P59923 | |
| GCGKSFTRAEHLKGH | 486 | P98168 | |
| SHSGEKSHTCGECGK | 191 | Q9UK13 | |
| CGKGFGHSSDFKRHR | 836 | A6NFI3 | |
| ECGKAFSQKSHLVRH | 666 | Q5MCW4 | |
| GHHLKACRAVAFSED | 81 | Q9H6Y2 | |
| CGKSFSHKGSLVQHQ | 291 | Q8TF45 | |
| GKCFSQKGTLTEHHR | 376 | Q8TF45 | |
| INHEKNGADGKHCES | 201 | Q6NX49 | |
| DKTHQCNECGKAFRH | 341 | P49910 | |
| FHSGEKSHTCNECGK | 161 | Q9UIE0 | |
| GVHKREKAFSHNNCG | 226 | A6NK53 | |
| ECGKAFSQSAHLRKH | 381 | P17020 | |
| KNCEGYGTEDHHKNL | 86 | Q68EA5 | |
| ECGKSFSHRANLTKH | 276 | P0CG31 | |
| HDGEKHFECSFCGKS | 276 | Q6P280 | |
| EEGSGAEVHRKHSKC | 156 | Q8IYR6 | |
| GEKCQFAHGFHELRS | 171 | P47974 | |
| GHGNLHFKKGCESVD | 116 | Q96H40 | |
| LHTGEKHYHCNDCGK | 351 | O43309 | |
| KCGKAFRHSSGLVEH | 386 | Q8NCK3 | |
| KKGKCESHQHGSEER | 211 | Q6NUM6 | |
| QLADGFCEKGHAHAA | 1201 | O75962 | |
| DCGKSFNEKGHLRNH | 636 | B7Z6K7 | |
| TGERHHVCSECGKAF | 526 | Q9Y473 | |
| ECGKAFNGRSNFHKH | 591 | Q9Y473 | |
| ERHHKCSECGKAFTQ | 411 | P51508 | |
| EHYKCSERGKAFHQG | 91 | P51522 | |
| HECNECGKAFKHSSG | 281 | Q96NJ6 | |
| CGKAFKHSSGLIRHQ | 286 | Q96NJ6 | |
| KCHESVHAREKQGFF | 531 | Q8WTR7 | |
| ECGKAFNRSSHLTKH | 376 | Q9Y2Q1 | |
| ASHQRVHAEGKSCKG | 336 | Q96N77 | |
| KGCDIFAGHANKHSV | 1201 | Q8WXR4 | |
| LEHQAVHTGDKSFGC | 501 | P28698 |